KRBP insider transactions
Kiromic BioPharma Inc. (KRBP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for KRBP
- Chief Executive Officer Bersani Pietro bought $7,407 worth of shares (3,488 units at $2.12), increasing direct ownership by 3% to 142,333 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- Chief Financial Officer Hungerford Brian bought $8,802 worth of shares (4,000 units at $2.20), increasing direct ownership by 7% to 64,933 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- Chief Financial Officer Hungerford Brian bought $3,500 worth of shares (2,000 units at $1.75), increasing direct ownership by 3% to 60,933 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- Director Misajon Pamela bought $5,288 worth of shares (1,610 units at $3.28), increasing direct ownership by 6% to 28,811 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- CFO Hungerford Brian bought $2,600 worth of shares (1,000 units at $2.60), increasing direct ownership by 2% to 58,933 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- Director Nagel Michael bought $3,330 worth of shares (1,000 units at $3.33), increasing direct ownership by 2% to 43,296 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- Director Misajon Pamela bought $4,984 worth of shares (1,701 units at $2.93), increasing direct ownership by 7% to 27,201 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- CFO Hungerford Brian bought $3,180 worth of shares (1,000 units at $3.18), increasing direct ownership by 2% to 57,933 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- CEO Bersani Pietro bought $19,530 worth of shares (6,000 units at $3.25), increasing direct ownership by 5% to 138,845 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Ralston Shannon4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 3 filed by new insider Ralston Shannon3 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- New insider Mirandola Leonardo claimed ownership of 56,926 units of Restricted Stock Award (SEC Form 3)3 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- Hungerford Brian was granted 56,933 units of Restricted Stock Award (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- Bersani Pietro was granted 45,968 units of Restricted Stock Award (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- Catlin Michael was granted 18,000 units of Restricted Stock Award, increasing direct ownership by 240% to 25,500 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- Misajon Pamela was granted 18,000 units of Restricted Stock Award, increasing direct ownership by 240% to 25,500 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- Nagel Michael was granted 18,000 units of Restricted Stock Award, increasing direct ownership by 74% to 42,296 units (SEC Form 4)4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Bersani Pietro4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Misajon Pamela4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Nagel Michael4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Catlin Michael4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Hungerford Brian4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 3 filed by new insider Hungerford Brian3 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 3 filed by new insider Catlin Michael3 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 3 filed by new insider Misajon Pamela3 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4: Dahlbeck Scott was granted 50,000 shares, increasing direct ownership by 11% to 496,757 units4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4: Clark Daniel Grant was granted 50,000 shares, increasing direct ownership by 392% to 62,770 units4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4: Bersani Pietro was granted 638,298 shares4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Nagel Michael4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Cicchetti Americo4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Tirelli Francis X4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Reeves Karen4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4: Dahlbeck Scott converted options into 17,240 shares, increasing direct ownership by 4% to 446,757 units4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 3 filed by new insider Reeves Karen3 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 3 filed by new insider Tirelli Francis X3 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 3: New insider Clark Daniel Grant claimed ownership of 6,866 shares and claimed ownership of 29,516 units of Restricted Stock Units3 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4: Chiriva Internati Maurizio bought $10,357 worth of Common Stock (2,800 units at $3.70), increasing direct ownership by 0.20% to 1,378,072 units4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Ryan Michael Charles4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 3 filed by Ryan Michael Charles3 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Rotino Gianluca4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Nunez Ignacio4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 3 filed by Nunez Ignacio3 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Kiromic BioPharma, Inc.4 - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Gianluca Rotino4/A - Kiromic Biopharma, Inc. (0001792581) (Issuer)
- SEC Form 4 filed by Tony Tontat4/A - Kiromic Biopharma, Inc. (0001792581) (Issuer)